QP 04 - Lung Quick Pitch: Early Stage NSCLC and Limited Stage SCLC

Presentations

• 05:00pm - 05:05pm ET

  Phase 1 Trial of CT-Guided Stereotactic Adaptive Radiotherapy (CT-STAR) for Treatment of Ultra-Central Early-Stage Non-Small Cell Lung Cancer (NSCLC)

  Speaker: Alden D'Souza, MD, MPHS - Washington University in St. Louis School of Medicine, St Louis
• 05:10pm - 05:15pm ET

  Prospective Study of Surface Guided Radiation Therapy (SGRT) Alone or in Combination with Fiducials for Free Breathing (FB) vs. Breath Hold (BH) Stereotactic Body Radiation Therapy (SBRT) Treatments of the Lung

  Speaker: John Heinzerling, MD - Atrium Health Levine Cancer, Wake Forest School of Medicine, Southeast Radiation Oncology Group PA, Charlotte
• 05:15pm - 05:20pm ET

  Adebrelimab as Maintenance Therapy Following Hyperfractionated Simultaneous Integrated Boost Radiotherapy Plus Chemotherapy in Limited-Stage Small-Cell Lung Cancer: A Prospective, Multicenter, Single-Arm Phase II Trial

  Speaker: Jiayi Yu, MD, PhD - Peking University Cancer Hospital and Institute, Beijing
• 05:20pm - 05:25pm ET

  Optimizing Nodal Target Delineation in Limited-Stage Small Cell Lung Cancer: A Large-Scale, Multi-Institutional Study

  Speaker: Xiaolong Wang, MS - Shandong Cancer Hospital and Institute, jinan
• 05:25pm - 05:30pm ET

  Induction Immunochemotherapy followed by Definitive Radiotherapy in Patients with Limited-Stage Small Cell Lung Cancer: A Multicenter Study

  Speaker: Junxu Wen, MS - Shandong Cancer Hospital Affiliated to Shandong First Medical University, Jinan
• 05:30pm - 05:50pm ET

  Questions and Answers

  Speaker: Evan Osmundson, MD, PhD - Vanderbilt-Ingram Cancer Center, Nashville